What are the main indications for use?

It is used for treating metabolic acidosis, alkalizing urine, treating hyperacidity symptoms, and as an adjunct in certain drug poisonings.

What are the contraindications for this injection?

It is contraindicated for gastric lavage when swallowing strong acidosis and should not be used in cases of metabolic or respiratory alkalosis.

Sodium Bicarbonate Injection 500mg10ml Antacid

Name: Sodium Bicarbonate Injection 500mg10ml Antacid
Brand: Shandong Shenglu Pharmaceutical Co., Ltd.
SKU: 2178614605

Shandong, ChinaShandong Shenglu Pharmaceutical Co., Ltd.

US$0.01

20,000-99,999 Pieces

US$0.009

100,000+ Pieces

Sample price:US$2.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

500mg10ml

Suitable for

All Persons

State

Liquid

Shape

Ampoule

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

SL001

Drug Ad Approval No.

SL001

Drug Class

Antacid

Copp

Copp Is Available

Register Dossier

Available

COA

Available

Test Repot

Available

Authentication

GMP

Qualification Certificate

Complete

Transport Package

Carton

Specification

500mg10ml

Trademark

shenglu or OEM

Origin

China

HS Code

3001909099

Production Capacity

1 Billion/Year

Key features

Comprehensive Quality Certificates: Includes COPP, Register Dossier, COA, Test Report, GMP Authentication, and Complete Qualification Certificate.

Flexible Customization Options: Offers full customization, minor customization, and options based on samples or designs.

Long-Term Manufacturer Experience: Established in 2001 with over 20 years of export experience to Asia, Africa, and South America.

Strict Quality Control: 100% inspection for finished products including visual and function checks by 15 QA/QC inspectors.

Competitive Pricing Strategy: Mission to provide high-quality products with competitive prices and fast delivery globally.

Global Market Reach: Products exported to over 10 countries including Cambodia, Philippines, Vietnam, and Nigeria.

Robust Supply Chain: 150 supply chain partners and 7 production lines ensuring sustainable high-quality output.

Multiple Payment Methods: Accepts LC, T/T, D/P, PayPal, Small-amount payment, and Western Union for flexible transactions.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceIn-stock Capacity100% Finished Products Inspection

Shandong Shenglu Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤11.83h

AI-Powered supplier vetting

SummaryThe supplier demonstrates substantial pharmaceutical production capacity, national GMP certification, stable-quality claims, broad customization, OEM/ODM services, export experience, inventory capacity, and documented complaint/CAPA procedures. However, it is not identified as a professional technical supplier, lacks 3D software and SDK capabilities, reported no new products in the past year, and has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. Financial records are referenced for 2021–2023, but the provided information does not establish financial strength. Supplier-approval documentation lacks signatures or dates, while environmental and fire-drill evidence remains unknown.

Supplier typeThe supplier is presented as a pharmaceutical manufacturer with stated capacity for small-volume injections, tablets, capsules, and powder injections, and it provides OEM/ODM services. It is explicitly not classified as a professional technical supplier, so its primary profile is manufacturing rather than technical-service provision.

CertificationsThe company description states that the supplier has passed national GMP certification. This is direct evidence of a relevant pharmaceutical manufacturing certification, although no additional certifications are provided.

After-Sales capabilityThe supplier has clear and followed procedures for customer complaints and corrective/preventive actions, and it maintains quality assurance. However, it has no overseas agents or branches, no overseas warehouse or showroom, and offers overseas services in zero countries, limiting evidence of broad international after-sales coverage.

R&D capabilityThe supplier does not provide 3D software design services, has no available SDK, and reported no new products in the past year. Although it offers ODM services and design-based customization, the explicit evidence indicates limited demonstrated product and technical innovation.

Production capacityThe supplier reports large annual pharmaceutical production capacity, inventory capability, valid manufacturing contracts with associated subcontractors, and national GMP certification. These points directly support substantial and organized manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, and minor customization, as well as ODM services. This demonstrates broad customization coverage despite the absence of 3D software design services.

Client casesThe supplier reports that 71%–90% of total sales come from exports, has exported goods for 20 years, and provides OEM services for well-known brands. These statements support relevant customer and international business experience, although specific customer names or case details are not supplied.